Plasma Asymmetric Dimethylarginine and Incidence of Cardiovascular Disease and Death in the Community

被引:322
作者
Boeger, Rainer H. [1 ]
Sullivan, Lisa M. [2 ,3 ]
Schwedhelm, Edzard [1 ]
Wang, Thomas J. [2 ,5 ]
Maas, Renke [1 ]
Benjamin, Emelia J. [2 ,4 ]
Schulze, Friedrich [1 ]
Xanthakis, Vanessa [2 ,3 ]
Benndorf, Ralf A. [1 ]
Vasan, Ramachandran S. [2 ,4 ]
机构
[1] Univ Med Ctr Hamburg Eppendorf, Inst Expt & Clin Pharmacol, Clin Pharmacol Unit, Hamburg, Germany
[2] Framingham Heart Dis Epidemiol Study, Framingham, MA 01702 USA
[3] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA
[4] Boston Univ, Sch Publ Hlth, Div Cardiol, Boston, MA USA
[5] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA
基金
美国国家卫生研究院;
关键词
cardiovascular diseases; epidemiology; nitric oxide; population; risk factors; GLOMERULAR-FILTRATION-RATE; CORONARY-HEART-DISEASE; NITRIC-OXIDE SYNTHESIS; MYOCARDIAL-INFARCTION; RISK; SYNTHASE; ARGININE; EVENTS; ADMA; DYSFUNCTION;
D O I
10.1161/CIRCULATIONAHA.108.838268
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase, induces endothelial dysfunction. Although elevated ADMA has been associated with an increased risk of cardiovascular disease events and death in referral samples, the prognostic significance of ADMA in the community has not been adequately evaluated. Methods and Results-We related plasma ADMA, L-arginine (Arg), and the ratio of Arg to ADMA to the incidence of cardiovascular disease (fatal or nonfatal myocardial infarction, coronary insufficiency, angina pectoris, stroke or transient ischemic attack, intermittent claudication, or heart failure) and death in 3320 Framingham Offspring Study participants (1769 women; mean age, 59 years). Over a follow-up period of 10.9 years, 281 individuals of 2956 free of cardiovascular disease at baseline developed incident cardiovascular disease, and 285 participants died. In multivariable models adjusting for established risk factors and other biomarkers (B-type natriuretic peptide, renin, homocysteine, urine albumin excretion, and C-reactive protein), ADMA and the ratio of Arg to ADMA were significantly associated with all-cause mortality (adjusted-hazard ratio [HR] per 1-SD increment, 1.21; 95% CI, 1.07 to 1.37; and HR per 1-SD increment, 0.80; 95% CI, 0.69 to 0.93, respectively), whereas Arg was not (HR per 1-SD increment, 0.89; 95% CI, 0.77 to 1.02). We noted effect modification by diabetes status; ADMA was associated with death in individuals without diabetes (adjusted HR per 1-SD increment, 1.30; 95% CI, 1.13 to 1.50) but not in individuals with diabetes (adjusted HR per 1-SD increment, 0.85; 95% CI, 0.62 to 1.16). ADMA, Arg, and the ratio of Arg to ADMA were not associated with cardiovascular disease incidence (P > 0.10). Conclusions-In our large community-based sample, ADMA was significantly associated with all-cause mortality, particularly in nondiabetic individuals. ( Circulation. 2009; 119: 1592-1600.)
引用
收藏
页码:1592 / U65
页数:13
相关论文
共 41 条
  • [1] Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase
    Achan, V
    Broadhead, M
    Malaki, M
    Whitley, G
    Leiper, J
    MacAllister, R
    Vallance, P
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (08) : 1455 - 1459
  • [2] ADMA is independently related to flow-mediated vasodilation in subjects at low cardiovascular risk
    Ardigo, D.
    Stuehlinger, M.
    Franzini, L.
    Valtuena, S.
    Piatti, P. M.
    Pachinger, O.
    Reaven, G. M.
    Zavaroni, I.
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2007, 37 (04) : 263 - 269
  • [3] Asymmetric dimethylarginine (ADMA):: A novel risk marker in cardiovascular medicine and beyond
    Böger, RH
    [J]. ANNALS OF MEDICINE, 2006, 38 (02) : 126 - 136
  • [4] Asymmetric dimethylarginine (ADMA):: A novel risk factor for endothelial dysfunction -: Its role in hypercholesterolemia
    Böger, RH
    Bode-Böger, SM
    Szuba, A
    Tsao, PS
    Chan, JR
    Tangphao, O
    Blaschke, TF
    Cooke, JP
    [J]. CIRCULATION, 1998, 98 (18) : 1842 - 1847
  • [5] LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells -: Involvement of S-adenosylmethionine-dependent methyltransferases
    Böger, RH
    Sydow, K
    Borlak, J
    Thum, T
    Lenzen, H
    Schubert, B
    Tsikas, D
    Bode-Böger, SM
    [J]. CIRCULATION RESEARCH, 2000, 87 (02) : 99 - 105
  • [6] The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor
    Böger, RH
    [J]. CARDIOVASCULAR RESEARCH, 2003, 59 (04) : 824 - 833
  • [7] Evidence for the pathophysiological role of endogenous methylarginines in regulation of endothelial NO production and vascular function
    Cardounel, Arturo J.
    Cui, Hongmei
    Samouilov, Alexandre
    Johnson, Wesley
    Kearns, Patrick
    Tsai, Ah-Lim
    Berka, Vladomir
    Zweier, Jay L.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (02) : 879 - 887
  • [8] COX DR, 1972, J R STAT SOC B, V34, P187
  • [9] Dimethylarginine dimethylaminohydrolase regulates nitric oxide synthesis - Genetic and physiological evidence
    Dayoub, H
    Achan, V
    Adimoolam, S
    Jacobi, J
    Stuehlinger, MC
    Wang, BY
    Tsao, PS
    Kimoto, M
    Vallance, P
    Patterson, AJ
    Cooke, JP
    [J]. CIRCULATION, 2003, 108 (24) : 3042 - 3047
  • [10] Increased superoxide production in hypertensive patients with diabetes mellitus - Role of nitric oxide synthase
    Dixon, LJ
    Hughes, SM
    Rooney, K
    Madden, A
    Devine, A
    Leahey, W
    Henry, W
    Johnston, GD
    McVeigh, GE
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (06) : 839 - 843